First Analysis private equity companies
Below are some of the companies we are helping to build currently and others we have helped build in the past.
- Accellent Corp.
- Achilles Group
- AdvancePath Academics Inc.
- Alien Technology
- American Waste Services Inc.
- ANI Pharmaceuticals Inc.
- Aprimo Inc.
- Aspen Holdings Inc.
- bTrade Inc.
- CCS Medical
- Chrome River
- CiviGenics Inc.
- Community Education Centers Inc.
- Continental Waste Industries
- Correctional Systems Inc.
- Cosmed Group
- CSA Medical
- Cylex Inc.
- Data Critical Corp.
- DataSphere Technologies Inc.
- Dialogic Corp.
- Dynamic Healthcare Tech.
- EDR Inc.
- EraGen Biosciences
- Exodus Communications Inc.
- ExpertPlan Inc.
- Extraprise
- Finjan Inc.
- FutureHealth Corp.
- GAPbuster Worldwide
- GE Wind Energy
- Global Employment Solutions
- GreatFood.com
- Gyrodata Inc.
- IndX Software Corp.
- Initiate Systems
- InPhonic Inc.
- IPLogic
- Kelatron Corp.
- Knowlagent
- KTI Inc.
- Learning.com
- LifeStar Cos.
- M Cubed Technologies Inc.
- Magnify Holdings Corp.
- Matrix Service Co.
- Metalico Inc.
- Movero Inc.
- National Recovery Systems Inc.
- Neptun Light Inc.
- netBOA
- NitroSecurity
- NuCo2 Inc.
- Omnipoint Corp.
- Performance Materials Corp.
- Prosar Corp.
- Pure Cycle Corp.
- QPS Pharmaceutical Services LLC
- ReSearch Pharmaceutical Svcs.
- SDIX
- SeQual Technologies
- Serrot International Inc.
- SmartPros
- Sourcecorp Inc.
- SPI Manufacturing
- SquareTwo Financial
- SterilMed
- TCI Solutions Inc.
- Tetra Technologies Inc.
- The Cobalt Group Inc.
- Ti3 Inc.
- Toplander Corp.
- TransCore
- TransForce Inc.
- Trustwave
- Tut Systems Inc.
- USA Waste Services Inc.
- VPNet Inc.
- Wimba
- Worldprints.com
- Wright Express Corp.
CSA Medical Inc.
CSA Medical, headquartered in Baltimore, has developed and sells an innovative energy-based medical console that delivers a therapeutic spray of liquid nitrogen to freeze and destroy unwanted tissue in the body. This proprietary interventional platform, the Spray Cryotherapy System, is comprised of a device and specialty catheters that allow delivery of therapeutic doses of the cryogen. The company is the first to harness the power of extreme cold (-196 C) liquid nitrogen therapeutic energy delivery inside the body. The platform is FDA cleared, and the therapy is being utilized by leading healthcare institutions throughout the United States, with over 8,000 procedures completed to date. CSA is working to expand the therapy for use in new areas of significant unmet medical need.
Website and contact information: www.csamedical.com